Tags

Type your tag names separated by a space and hit enter

[Successful treatment with topiramate in a case of idiopathic intracranial hypertension refractory to acetazolamide].
No To Hattatsu. 2017 05; 49(3):207-10.NT

Abstract

A 6-year-old girl experienced nausea and vomiting for 3 weeks and double vision for 1 week prior to her first visit to our hospital. She had bilateral ophthalmoplegia from sixth cranial nerve palsy and papilledema. Her brain MRI showed normal brain parenchyma. The lumbar cerebrospinal fluid (CSF) opening pressure was 1000 mm of water measured with normal CSF contents. From these findings, she was diagnosed with idiopathic intracranial hypertension (IIH). Initial lumbar puncture (LP) immediately improved her symptoms, but acetazolamide, a first line drug for the treatment of IIH, failed to maintain the remission, and three more periodical LP were required to relieve her symptoms every 2 weeks. After the fourth LP, acetazolamide was switched to a second line drug for IIH, topiramate, which was found to be highly effective in controlling IIH in a short time period. The long process of IIH causes vision loss, therefore, its prompt treatment is vital. In cases refractory to medical treatment, surgical treatments such as CSF shunt are considered. Acetazolamide is used in most IIH cases after the initial diagnosis, but in this case, it was ineffective, and topiramate was highly effective. Both acetazolamide and topiramate are inhibitors of carbonic anhydrase isoforms involved in CSF secretion. Inhibition of choroid plexus carbonic anhydrase by these drugs leads to decreased CSF secretion and the consequent control of intracranial pressure. Higher isoform specificity and increased lipophilic nature of topiramate, which are advantageous for passing through the blood brain barrier, may be the reasons for better activity than acetazolamide, at least in the present case. Topiramate might be effective and should be considered for refractory IIH cases before surgical treatments.

Authors

No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Case Reports
Journal Article

Language

jpn

PubMed ID

30113799

Citation

Noda, Marie, et al. "[Successful Treatment With Topiramate in a Case of Idiopathic Intracranial Hypertension Refractory to Acetazolamide]." No to Hattatsu = Brain and Development, vol. 49, no. 3, 2017, pp. 207-10.
Noda M, Sonoda Y, Takemoto M, et al. [Successful treatment with topiramate in a case of idiopathic intracranial hypertension refractory to acetazolamide]. No To Hattatsu. 2017;49(3):207-10.
Noda, M., Sonoda, Y., Takemoto, M., & Kira, R. (2017). [Successful treatment with topiramate in a case of idiopathic intracranial hypertension refractory to acetazolamide]. No to Hattatsu = Brain and Development, 49(3), 207-10.
Noda M, et al. [Successful Treatment With Topiramate in a Case of Idiopathic Intracranial Hypertension Refractory to Acetazolamide]. No To Hattatsu. 2017;49(3):207-10. PubMed PMID: 30113799.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Successful treatment with topiramate in a case of idiopathic intracranial hypertension refractory to acetazolamide]. AU - Noda,Marie, AU - Sonoda,Yuri, AU - Takemoto,Megumi, AU - Kira,Ryutaro, PY - 2018/8/17/entrez PY - 2017/5/1/pubmed PY - 2018/12/13/medline SP - 207 EP - 10 JF - No to hattatsu = Brain and development JO - No To Hattatsu VL - 49 IS - 3 N2 - A 6-year-old girl experienced nausea and vomiting for 3 weeks and double vision for 1 week prior to her first visit to our hospital. She had bilateral ophthalmoplegia from sixth cranial nerve palsy and papilledema. Her brain MRI showed normal brain parenchyma. The lumbar cerebrospinal fluid (CSF) opening pressure was 1000 mm of water measured with normal CSF contents. From these findings, she was diagnosed with idiopathic intracranial hypertension (IIH). Initial lumbar puncture (LP) immediately improved her symptoms, but acetazolamide, a first line drug for the treatment of IIH, failed to maintain the remission, and three more periodical LP were required to relieve her symptoms every 2 weeks. After the fourth LP, acetazolamide was switched to a second line drug for IIH, topiramate, which was found to be highly effective in controlling IIH in a short time period. The long process of IIH causes vision loss, therefore, its prompt treatment is vital. In cases refractory to medical treatment, surgical treatments such as CSF shunt are considered. Acetazolamide is used in most IIH cases after the initial diagnosis, but in this case, it was ineffective, and topiramate was highly effective. Both acetazolamide and topiramate are inhibitors of carbonic anhydrase isoforms involved in CSF secretion. Inhibition of choroid plexus carbonic anhydrase by these drugs leads to decreased CSF secretion and the consequent control of intracranial pressure. Higher isoform specificity and increased lipophilic nature of topiramate, which are advantageous for passing through the blood brain barrier, may be the reasons for better activity than acetazolamide, at least in the present case. Topiramate might be effective and should be considered for refractory IIH cases before surgical treatments. SN - 0029-0831 UR - https://www.unboundmedicine.com/medline/citation/30113799/[Successful_treatment_with_topiramate_in_a_case_of_idiopathic_intracranial_hypertension_refractory_to_acetazolamide]_ L2 - http://www.medicalonline.jp/meteo_linkout.php?issn=0029-0831&volume=49&issue=3&spage=207 DB - PRIME DP - Unbound Medicine ER -